LifeStance director proposes $1.10M share sale
Kenneth A. Burdick also reported sales of 500,000 shares on August 11 and 66,589 shares on November 9, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. (LFST) director Kenneth A. Burdick gave notice of a proposed sale of 75,000 common shares, with an approximate sale date of November 10, 2026 and aggregate market value of $1,095,081.98. Fidelity Brokerage Services LLC is listed as the broker.
The 75,000 shares were acquired from the issuer through a cash stock option exercise on November 10, 2026. Gary Redman signed as Fidelity Brokerage Services LLC’s duly authorized representative and attorney-in-fact for Kenneth A. Burdick.
Key Figures
Key Terms
Stock Option Exercise financial
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.